Advertisement
Corrigendum| Volume 177, P206-207, December 2022

Download started.

Ok

Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241]

Published:October 27, 2022DOI:https://doi.org/10.1016/j.ejca.2022.09.019
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241]
Previous ArticleLetter re: “Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancer”
Next ArticleErratum to ‘Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma’ [Eur J Cancer 170 (2022) 209-235]
      The authors regret that Carles Fabregat-Franco's name was incorrectly given in the original article as Carles Fabregat. This has now been corrected in the online article. The correct author details are:
      Carles Fabregat-Franco b
      b Gastrointestinal Cancer Unit, Vall d’Hebron University Hospital & Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
      The authors would like to apologize for any inconvenience caused.

      Article info

      Publication history

      Published online: October 27, 2022

      Identification

      DOI: https://doi.org/10.1016/j.ejca.2022.09.019

      Copyright

      © 2022 Elsevier Ltd. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX